3D Bioprinting Market by Covid-19 Impact, Competitive Landscape, SWOT Analysis, Opportunities and Challenges, Growth by 2022-2027
Research Reports
Mar 18, 2022
Market Analysis
The global 3D bioprinting market is likely to touch USD 1923.02 million at a whopping 24.59?GR between 2018-2023, as per the recent Market Research Future (MRFR) report. 3D bioprinting includes various 3D printing techniques to combine biomaterials and cells for producing biomedical parts. It has wide applications, including clinical and research.
Numerous factors are adding to the global 3D bioprinting market growth. These factors, according to the recent Market Research Future report, include growing need for transplantation of organs, rising investment in R&D activities, increasing geriatric population, technological advances to manufacture custom made products, innovations, and developments in 3D bioprinting, and increasing use in cosmetic surgery and drug discovery.
On the flipside, limitations on products that are biomaterial-based coupled with socio-ethical concerns may limit the market growth during the forecast period.
Key Players
Notable players profiled in the 3D bioprinting market report include FUJIFILM Wako Automation Corporation (U.S.), Nano3D Biosciences Inc. (U.S.), Organovo Holdings Inc. (U.S.), REGENHU Ltd. (Switzerland), Aspect Biosystems Ltd. (Canada), Allevi (U.S.), Regenovo Biotechnology Co. Ltd. (China), EnvisionTEC GmbH (Germany), Stratasys Ltd. (U.S.), Cyfuse Biomedical K.K. (Japan), Poietis (France), and Cellink AB (Sweden).
Get Sample Report: https://www.marketresearchfuture.com/sample_request/869
Market Segmentation
Based on the segment, the global 3D bioprinting market has been segmented based on material, end user, technology, and application.
By technology, the global 3D bioprinting market has been segmented into inkjet 3D bioprinting, microextrusion bioprinting, magnetic 3D bioprinting, and laser-assisted bioprinting. Among these, microextrusion bioprinting will lead the market during the forecast period for its extensive applications in bioprinting.
By material, the global 3D bioprinting market has been segmented into hydrogels, living cells, and extracellular matrices. Among these, living cells will have the largest share in the market during the forecast period.
By applications, the market has been segmented into research and clinical applications. Among these, research applications will dominate the market during the forecast period for its extensive application in 3D cell culture and regenerative medicine.
By end users, the global 3D bioprinting market has been segmented into pharmaceutical & biotechnology companies and research organizations & academic institutes. Among these, pharmaceutical & biotechnology companies will hold the largest share in the market during the forecast period.
Regional Analysis
By region, the global 3D bioprinting market has been segmented based on the following regions- the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Among these, the Americas will dominate the 3D bioprinting market over the forecast period and is likely to touch USD 689.91 million by the end of 2023. Factors propelling market growth in this region comprise the creation of 3D printed pills, which are custom made as per an individual’s age and weight, presence of well-established healthcare infrastructure, burgeoning demand for organs, and huge investments in the research and development activities.
In the Asia Pacific region, the global 3D bioprinting market will grow at a quick pace. It is likely to grow at a 27.25?GR and touch USD 507.18 million over the forecast period. Factors propelling market growth in this region comprise huge funds from the government to accelerate the pace of the 3D printing technology, developments and innovations in the healthcare sector, and plentiful opportunities.
In Europe, the global 3D bioprinting market will have a remarkable growth during the forecast period and is likely to touch USD 649.91 million by the end of 2023. Factors propelling market growth in the region comprise agreements between industry players, rising cases of cosmetic surgery, and increasing emphasis on health & wellness.
In the MEA, the global 3D bioprinting market will have a slow growth during the forecast period.
Industry News
Feb 2020: UPM has recently launched bioinks, called GrowInk. It has been designed for different 3D bioprinting applications, including regenerative medicine and tissue engineering. Water and nano fibrillar cellulose are the two key components of this bioink. This is integrated for offering a defined matrix that can be mixed directly with cells as well as customized. It will be available in three variants- GrowInk-N, GrowInk-T, and GrowInk-ALG.
Browse Full Report @ https://www.marketresearchfuture.com/sample_request/869
Browse Related Report:
Pharmaceutical Grade Lactose Market Research Report- forecast till 2027
Intracranial Pressure (ICP) Monitoring Market Research Report – Global Forecast to 2027
Home Medical Equipment Market Research Report – Global Forecast till 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact Information:
Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street,5Th Floor, New York, New York 10013 Email: sales@marketresearchfuture.com
Tags:
PR-Wirein, Wire, Research Newswire, English